Business
ICON Schedules Fourth Quarter and Full Year 2025 Earnings Conference Call and Acknowledges Receipt of Deficiency Notice from Nasdaq
DUBLIN, May 26, 2026--ICON Schedules Fourth Quarter and Full Year 2025 Earnings Conference Call and Acknowledges Receipt of Deficiency Notice from Nasdaq
About this update from Icon Plc
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/8116a98248e8ef2147697081dc616998"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/2kPoPSvHNGZkZDC6yjTe9Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MA--/https://media.zenfs.com/en/business-wire.com/8116a98248e8ef2147697081dc616998","width":960,"height":480},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/vque8nJVNB4Bm2ad3UaO5w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTMyMA--/https://media.zenfs.com/en/business-wire.com/8116a98248e8ef2147697081dc616998","width":640,"height":320},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/9hAXznf2GYjqF0OG03Ba8w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0/https://media.zenfs.com/en/business-wire.com/8116a98248e8ef2147697081dc616998","width":1024,"height":512}},"lazy":false},{"type":"text","content":"DUBLIN, May 26, 2026--(BUSINESS WIRE)--ICON plc (NASDAQ: ICLR), a world-leading clinical research organization, today announced that it will release financial results for the fourth quarter and full year 2025 results after the market closes on Wednesday, May 27, 2026. The Company will hold a conference call and webcast to discuss its financial results and performance on Thursday, May 28, 2026 at 8:00am ET.","length":409,"tagName":"p"},{"type":"text","content":"The Company also announced that, as expected, as a consequence of not yet having filed its Annual Report on Form 20-F for the year ended December 31, 2025 (the "Form 20-F"), the Company has received a written notice from Nasdaq indicating that it is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Listing Rule"), which requires timely filing of all required periodic financial reports with the U.S. Securities and Exchange Commission.","length":467,"tagName":"p"},{"type":"text","content":"The notice has no immediate impact on the listing or trading of the Company’s securities. Nasdaq has provided the Company with 60 calendar days from the date of the notice to submit a plan to regain compliance.","length":210,"tagName":"p"},{"type":"text","content":"The Company expects to regain compliance upon filing the Form 20-F, which it currently anticipates completing in advance of the conference call.","length":144,"tagName...